DK2857019T3 - Fremgangsmåde til behandling af multipel sklerose - Google Patents
Fremgangsmåde til behandling af multipel sklerose Download PDFInfo
- Publication number
- DK2857019T3 DK2857019T3 DK14194213.6T DK14194213T DK2857019T3 DK 2857019 T3 DK2857019 T3 DK 2857019T3 DK 14194213 T DK14194213 T DK 14194213T DK 2857019 T3 DK2857019 T3 DK 2857019T3
- Authority
- DK
- Denmark
- Prior art keywords
- multiple sclerosis
- treating multiple
- treating
- sclerosis
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1257254A FR2993780B1 (fr) | 2012-07-26 | 2012-07-26 | Methode de traitement de la sclerose en plaque |
| US13/644,615 US8835487B2 (en) | 2012-07-26 | 2012-10-04 | Method of treating multiple sclerosis |
| EP13719836.2A EP2729143B1 (en) | 2012-07-26 | 2013-04-29 | Use of biotin for the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2857019T3 true DK2857019T3 (da) | 2020-08-17 |
Family
ID=47294963
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14194213.6T DK2857019T3 (da) | 2012-07-26 | 2013-04-29 | Fremgangsmåde til behandling af multipel sklerose |
| DK13719836.2T DK2729143T3 (da) | 2012-07-26 | 2013-04-29 | Anvendelse af biotin til behandling af multipel sklerose |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13719836.2T DK2729143T3 (da) | 2012-07-26 | 2013-04-29 | Anvendelse af biotin til behandling af multipel sklerose |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8835487B2 (da) |
| EP (2) | EP2729143B1 (da) |
| JP (1) | JP6208235B2 (da) |
| KR (1) | KR101967502B1 (da) |
| CN (2) | CN109908140A (da) |
| AU (1) | AU2013295370B2 (da) |
| BR (1) | BR112015001562A2 (da) |
| CA (1) | CA2879434C (da) |
| CY (1) | CY1116304T1 (da) |
| DK (2) | DK2857019T3 (da) |
| EA (1) | EA030478B1 (da) |
| ES (3) | ES2811074T3 (da) |
| FR (1) | FR2993780B1 (da) |
| HK (1) | HK1207583A1 (da) |
| HR (1) | HRP20150260T1 (da) |
| HU (1) | HUE024558T2 (da) |
| IL (1) | IL236790A (da) |
| LT (1) | LT2857019T (da) |
| ME (1) | ME02060B (da) |
| PL (1) | PL2729143T3 (da) |
| PT (2) | PT2729143E (da) |
| RS (1) | RS53893B1 (da) |
| SI (2) | SI2857019T1 (da) |
| SM (1) | SMT201500057B (da) |
| WO (1) | WO2014016003A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
| CA2910717C (en) | 2013-04-29 | 2021-01-26 | Assistance Publique - Hopitaux De Paris | Biotin for use in treating x-linked adrenoleukodystrophy |
| JP6108045B2 (ja) * | 2015-02-13 | 2017-04-05 | ユニマテック株式会社 | 含フッ素共重合体およびこれを有効成分とする表面改質剤 |
| EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| WO2017086835A1 (ru) * | 2015-11-17 | 2017-05-26 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты) |
| RU2611415C1 (ru) * | 2015-11-17 | 2017-02-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты) |
| RU2638803C2 (ru) * | 2016-06-09 | 2017-12-15 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Таблетки биотина с замедленным высвобождением и способ их получения |
| EP3275439A1 (en) * | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
| JP2019526638A (ja) | 2016-09-01 | 2019-09-19 | ジェイディーエス・セラピューティクス、エルエルシー | ビオチン酸マグネシウム組成物および使用方法 |
| RU2639488C1 (ru) * | 2017-04-06 | 2017-12-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Фармацевтическая композиция, содержащая биотин, и способ ее получения |
| US20200155510A1 (en) * | 2018-11-13 | 2020-05-21 | Jds Therapeutics, Llc | Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions |
| CN112076310A (zh) * | 2019-06-14 | 2020-12-15 | 苏州融析生物科技有限公司 | 一种治疗多发性硬化的药物组合物及其制备 |
| AU2020407071A1 (en) | 2019-12-16 | 2022-07-07 | Nutrition 21, Llc | Methods of production of arginine-silicate complexes |
| CA3157712C (en) | 2020-01-01 | 2024-01-23 | Jotiram PALKAR | Synergistic nutritional compositions for enhancing atp efficiency |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609165A (en) | 1968-07-19 | 1971-09-28 | Research Corp | 1,3-diazabicyclo {8 3.1.0{9 {0 hex-3-enes |
| JPH0995448A (ja) | 1995-09-29 | 1997-04-08 | Calpis Food Ind Co Ltd:The | 血中ビオチン濃度の増加方法およびビオチン含有飲食品 |
| EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
| US5789401A (en) | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
| US6664039B1 (en) | 1998-10-14 | 2003-12-16 | California Institute Of Technology | Methods and compositions for modulating neurodegeneration |
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| DE19903241A1 (de) | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Galenische Formulierung |
| US20050256178A1 (en) | 2002-08-23 | 2005-11-17 | Eggersdorfer Manfred L | Novel nutraceutical compositions comprising boitin |
| CN100362987C (zh) | 2002-09-30 | 2008-01-23 | 第一制药株式会社 | 含有双泛酰硫乙胺的粒状物 |
| DE10341240A1 (de) * | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| WO2005067972A1 (en) * | 2003-12-31 | 2005-07-28 | Integrative Health Consulting, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
| IL162288A0 (en) * | 2004-06-01 | 2005-11-20 | Future Products Man S A | Compositions and methods for treating neurodegenerative disorders |
| BG66011B1 (bg) * | 2005-05-25 | 2010-10-29 | Райна Щонова | Състав от растителен произход |
| US20130004545A1 (en) | 2009-12-23 | 2013-01-03 | Lupin Limited | Slow release pharmaceutical compositions of iloperidone |
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
-
2012
- 2012-07-26 FR FR1257254A patent/FR2993780B1/fr not_active Expired - Fee Related
- 2012-10-04 US US13/644,615 patent/US8835487B2/en active Active
-
2013
- 2013-04-29 AU AU2013295370A patent/AU2013295370B2/en not_active Ceased
- 2013-04-29 PT PT13719836T patent/PT2729143E/pt unknown
- 2013-04-29 SI SI201331768T patent/SI2857019T1/sl unknown
- 2013-04-29 PT PT141942136T patent/PT2857019T/pt unknown
- 2013-04-29 LT LTEP14194213.6T patent/LT2857019T/lt unknown
- 2013-04-29 KR KR1020157004516A patent/KR101967502B1/ko not_active Expired - Fee Related
- 2013-04-29 BR BR112015001562A patent/BR112015001562A2/pt not_active Application Discontinuation
- 2013-04-29 HR HRP20150260TT patent/HRP20150260T1/hr unknown
- 2013-04-29 JP JP2015523453A patent/JP6208235B2/ja not_active Expired - Fee Related
- 2013-04-29 HU HUE13719836A patent/HUE024558T2/hu unknown
- 2013-04-29 RS RS20150168A patent/RS53893B1/sr unknown
- 2013-04-29 EA EA201590270A patent/EA030478B1/ru not_active IP Right Cessation
- 2013-04-29 EP EP13719836.2A patent/EP2729143B1/en active Active
- 2013-04-29 EP EP14194213.6A patent/EP2857019B1/en active Active
- 2013-04-29 ES ES14194213T patent/ES2811074T3/es active Active
- 2013-04-29 DK DK14194213.6T patent/DK2857019T3/da active
- 2013-04-29 HK HK15108330.5A patent/HK1207583A1/xx unknown
- 2013-04-29 DK DK13719836.2T patent/DK2729143T3/da active
- 2013-04-29 CN CN201910026016.2A patent/CN109908140A/zh active Pending
- 2013-04-29 PL PL13719836T patent/PL2729143T3/pl unknown
- 2013-04-29 ES ES13719836.2T patent/ES2532364T3/es active Active
- 2013-04-29 SI SI201330023T patent/SI2729143T1/sl unknown
- 2013-04-29 WO PCT/EP2013/058936 patent/WO2014016003A1/en not_active Ceased
- 2013-04-29 ME MEP-2015-32A patent/ME02060B/me unknown
- 2013-04-29 CN CN201380039687.3A patent/CN104602689A/zh active Pending
- 2013-04-29 CA CA2879434A patent/CA2879434C/en not_active Expired - Fee Related
-
2014
- 2014-01-14 ES ES14700423.8T patent/ES2626079T3/es active Active
- 2014-08-13 US US14/458,625 patent/US9351961B2/en not_active Expired - Fee Related
-
2015
- 2015-01-19 IL IL236790A patent/IL236790A/en active IP Right Grant
- 2015-03-09 SM SM201500057T patent/SMT201500057B/xx unknown
- 2015-03-11 CY CY20151100243T patent/CY1116304T1/el unknown
-
2016
- 2016-04-12 US US15/096,957 patent/US10201528B2/en not_active Expired - Fee Related
-
2018
- 2018-12-21 US US16/231,111 patent/US20190117626A1/en not_active Abandoned
- 2018-12-21 US US16/231,073 patent/US20190117625A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2857019T3 (da) | Fremgangsmåde til behandling af multipel sklerose | |
| DK2709613T4 (da) | Fremgangsmåder til behandling af hcv | |
| DK2970383T3 (da) | Fremgangsmåde til behandling af fibrose | |
| DK2906696T3 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
| BR112014032116A2 (pt) | método. | |
| DK3225604T3 (da) | Fremgangsmåde til fremstilling af flerlagsruder | |
| DK2804548T3 (da) | Apparat til okklusionsfjernelse | |
| DK2837629T3 (da) | Fremgangsmåde til syntetisering af sapropterindihydrochlorid | |
| EP2812344A4 (en) | SUBSTRATES, PEPTIDE NETWORKS AND METHODS | |
| FI20125613L (fi) | Menetelmä ligniinin fraktioimiseksi | |
| CU24158B1 (es) | Método de obtención de 1-kestosa | |
| BR112014009795A2 (pt) | método | |
| BR112014007958A2 (pt) | método | |
| BR112014001851A2 (pt) | método | |
| BR112014001237A2 (pt) | método | |
| HUE046544T2 (hu) | Eljárások Hepatitis C kezelésére | |
| DK2876447T3 (da) | Fremgangsmåde til detektering af cancer | |
| DK2956071T3 (da) | Sæt til perifer nerveblokering | |
| DK2893781T3 (da) | Fremgangsmåde til fremstilling af fleksible kredsløb | |
| DK2812013T3 (da) | Formulering til behandling af IBS | |
| DK2834229T3 (da) | Fremgangsmåde til fremstilling af ccr3-inhibitorer | |
| DK2809782T3 (da) | Forbedret fremgangsmåde til fremstilling af makrokugler | |
| DK2788353T3 (da) | Bur-aminligander til metallo-radiofarmaceutika | |
| DK3016682T3 (da) | Metoder til behandling af kræft | |
| DK2916661T3 (da) | Fremgangsmåde til opnåelse af bloom-hæmmende komponenter til konfektureprodukter |